Enterococcus Faecalis

If you are trying to conceive, going through IVF, or watching for hidden causes of recurring vaginal symptoms, the bacteria living in your vagina matter more than most people realize. Enterococcus faecalis is a vaginal pathobiont, meaning it can sit quietly as part of the normal community in some women but contribute to problems in others, and finding it on a swab is one clue about what is happening in your reproductive tract.

This swab tells you whether E. faecalis (Enterococcus faecalis) is detectable in your vaginal sample. Its presence has been linked in some studies to reduced protective bacteria, poorer IVF outcomes when combined with certain other organisms, more severe HPV-related cervical changes in some groups, and increased risk of preterm prelabor rupture of membranes during pregnancy. The evidence is mixed, and this is a research-grade marker, but in the right context it can change the next step you take.

What This Bacterium Actually Is

E. faecalis is not a hormone, protein, or hormone-like signal. It is a living bacterium that the lab detects by its DNA or by growing it from your swab. Your body does not make it. It either lives in your vaginal community or it does not, and its presence reflects the composition of the bacterial ecosystem inside the vagina.

A healthy vaginal community is often dominated by protective bacteria called lactobacilli, which keep the environment acidic and crowd out other microbes. When E. faecalis shows up in meaningful amounts, it can signal that this protective layer has thinned. In one study of infertile women, vaginal swabs positive for E. faecalis were linked to reduced vaginal lactobacilli, a hallmark of a state called dysbiosis (an imbalance in the bacterial community). That said, E. faecalis has also been described as a commensal organism in some populations, including a notable share of healthy Cameroonian and Northeast Indian women, so its presence is not automatically a sign of disease.

Fertility and IVF Outcomes

This is where the data gets the most attention, though the evidence is more limited than it can appear at first glance. In a single-center study of 285 couples undergoing IVF, about 46% had an asymptomatic genital tract infection, and E. faecalis was the most prevalent species in positive semen samples (11.6%). In that same study, couples where E. faecalis was co-detected with Ureaplasma urealyticum or Mycoplasma hominis had an IVF success rate of just 7.5%, compared with 85.7% in couples whose samples were clean.

Those numbers are dramatic but come from one study. A 2024 systematic review and meta-analysis of 25 studies covering 6,835 IVF patients found that vaginal dysbiosis correlated with higher early pregnancy loss and lower clinical pregnancy rates but had no statistically significant impact on live birth rates. A 2025 retrospective analysis of 475 couples found similar clinical pregnancy rates between women with positive and negative vaginal cultures (36% vs. 39%). A Cochrane review also found insufficient evidence to support routine antibiotic use before embryo transfer. The takeaway: knowing whether this bacterium is present can be useful information, especially if you have other risk factors, but the case for treating it before IVF as a universal step is not yet settled.

Pregnancy and Preterm Rupture of Membranes

In a study of pregnant women in Western China, vaginal E. faecalis was one of the top opportunistic bacteria found in pregnancies complicated by preterm prelabor rupture of membranes (when the water breaks weeks before the due date). It was identified as an indicator species, meaning its presence helped distinguish pregnancies that went on to develop this complication from those that did not.

Reviews of aerobic vaginitis, a type of inflammatory vaginal infection in which E. faecalis is a key player, group it with bacteria like group B streptococcus and E. coli that increase obstetric risk. The evidence here points toward earlier screening and treatment in pregnancies where this organism shows up, especially when symptoms or other risk factors are present.

HPV and Cervical Changes

In a study of Taiwanese women, E. faecalis was found in higher quantities in those with CIN1 (the earliest grade of cervical intraepithelial neoplasia, the precancerous cell changes that can follow HPV infection) compared with HPV-negative women. Separate work found Enterococcus species more represented in HPV-positive women than HPV-negative women. The broader HPV-microbiome literature actually points to Gardnerella, Sneathia, Prevotella, and Fannyhessea, rather than E. faecalis, as the organisms most consistently associated with cervical disease progression. E. faecalis enrichment may be one piece of a less protective local environment, but it is not the dominant microbial signal in HPV-related cervical changes.

Making Sense of a Mixed Picture

Not every study points the same direction. In a large epidemiologic analysis of Ecuadorian women, E. faecalis was detected in only 1.7% of vaginal samples and was the one opportunistic pathogen with no statistical link to any pattern of vaginal microbiota or symptoms. In some healthy women in Northeast India, E. faecalis can even be a dominant vaginal species without obvious disease, and Cameroonian women carry it commonly as part of their lactic acid bacterial community.

This is not a contradiction so much as a reminder that the meaning of a positive result depends on context. The same bacterium can sit quietly in one person's vagina, displace protective bacteria in another, and tip the balance toward obstetric or fertility consequences in a third. The clinical weight of your result depends on what else is going on: your lactobacilli levels, whether other pathogens are co-detected, your pregnancy status, your fertility goals, and your symptoms.

Why One Reading Is Not Enough

The vaginal microbiome shifts with the menstrual cycle, sexual activity, recent antibiotic use, douching, and even underwear changes. A single swab captures only a snapshot. If E. faecalis shows up, repeating the test after treatment or a few weeks later can confirm whether the finding is persistent or transient. If it does not show up but you have ongoing symptoms or fertility concerns, retesting at a different point in your cycle can change the picture.

A practical cadence for someone actively managing reproductive health: a baseline swab when you start investigating, a follow-up swab 4 to 6 weeks after any antibiotic or probiotic intervention to verify clearance, and additional swabs before key events like an IVF cycle or in early pregnancy if you have a history of preterm rupture or recurrent dysbiosis.

When Results Can Be Misleading

• Recent antibiotic use: systemic antibiotics, including those given during labor or for any infection elsewhere in the body, can temporarily change the bacteria detected on a vaginal swab. Of note, E. faecalis is intrinsically resistant to metronidazole, so courses of that drug can shift the surrounding bacterial community without clearing E. faecalis itself.
• Sampling technique and timing: swabs taken too close to the cervix, after intercourse, during menses, or right after douching can shift what grows. A clean, mid-vaginal sample taken outside menses gives the most reliable signal.
• Local antibiotic or probiotic products: intravaginal metronidazole, clindamycin, or probiotic suppositories used within the past two weeks can suppress or alter what the swab detects without reflecting your usual baseline.
• Pregnancy and hormonal status: the vaginal community changes meaningfully across pregnancy, the menstrual cycle, and menopause. A result in early pregnancy is not directly comparable to one taken postpartum or while on hormonal contraception.

What to Do With an Unexpected Result

If E. faecalis comes back positive, the next steps depend on your situation rather than the number alone. If you are trying to conceive or planning IVF, talk to your fertility specialist about whether treatment is appropriate. Targeted antibiotic therapy guided by sensitivity testing may be reasonable in some cases, but the evidence for routinely treating before embryo transfer is not strong, and metronidazole specifically will not clear E. faecalis. If you are pregnant, especially in the second or third trimester, the finding warrants a conversation with your obstetrician about monitoring for signs of aerobic vaginitis or preterm rupture risk.

Companion tests that sharpen the picture include a full vaginal microbiome panel showing your lactobacilli profile, tests for Ureaplasma urealyticum and Mycoplasma hominis (since the IVF risk signal in research came from combinations of these organisms), screening for bacterial vaginosis markers like Gardnerella vaginalis, and HPV testing if cervical health is a concern. If you have recurrent positive swabs despite treatment, a referral to a reproductive infectious disease specialist or a urogynecologist with microbiome expertise is appropriate.